FGA
TXG icon

Fortis Group Advisors’s 10x Genomics TXG Stock Holding History

Fortis Group Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$348K Sell
15,794
-67,124
-81% -$1.34M 0.06% 216
2025
Q4 		$1.67M Buy
82,918
+62,766
+311% +$948K 0.28% 92
2025
Q3 		$275K Buy
+20,152
New +$263K 0.05% 201

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fortis Group Advisors's TXG Position: Q1 2026 in Review

Fortis Group Advisors reduced its 10x Genomics (TXG) stake by 81% in Q1 2026, selling an estimated $1.34M and leaving 15,794 shares worth $348K. The position accounts for 0.06% of the portfolio, ranked #216.

Fortis Group Advisors first reported a position in TXG in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.67M in Q4 2025. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Fortis Group Advisors held 15,794 shares of 10x Genomics worth $348K as of Q1 2026.
  • Fortis Group Advisors sold 67,124 10x Genomics shares in Q1 2026, an estimated $1.34M.
  • 10x Genomics made up 0.06% of Fortis Group Advisors's portfolio in Q1 2026, its #216 holding.
  • Fortis Group Advisors first reported a position in 10x Genomics in Q3 2025 and has held it in 3 quarters since.
  • Fortis Group Advisors's 10x Genomics position peaked at $1.67M in Q4 2025.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Fortis Group Advisors's 13F filing for Q1 2026, filed 8 May 2026.